Shilpa Medicare informs about revised disclosure

27 Sep 2024 Evaluate
Shilpa Medicare has informed that it enclosed the revised Disclosures of reasons for encumbrance by promoter of listed companies under Regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 26, 2024 for Ramakant Innani.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

316.05 2.85 (0.91%)
16-Mar-2026 15:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.50
Dr. Reddys Lab 1278.85
Cipla 1302.30
Zydus Lifesciences 889.60
Lupin 2290.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×